Giulia Siravegna

Candiolo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Critical Questions in Genomic Diagnostics for Veterinary Oncology: What We Need to Know.

Critical Questions in Genomic Diagnostics for Veterinary Oncology: What We Need to Know.

Journal: Veterinary and comparative oncology

Published: May 15, 2025

Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.

Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.

Journal: JAMA network open

Published: November 17, 2023

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 12, 2023

Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential.

Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential.

Journal: Veterinary and comparative oncology

Published: July 28, 2023

Editorial: The impact of genetics on CRC therapy: from adaptive mutability to drug resistance.

Editorial: The impact of genetics on CRC therapy: from adaptive mutability to drug resistance.

Journal: Frontiers in oncology

Published: July 17, 2023

Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma.

Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 04, 2023

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial.

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial.

Journal: Nature medicine

Published: June 12, 2022

Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.

Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.

Journal: Cancer

Published: October 15, 2021

Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer.

Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 12, 2021

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation.

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation.

Journal: Cancer discovery

Published: March 19, 2021

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 01, 2021

How to use liquid biopsies to treat patients with cancer.

How to use liquid biopsies to treat patients with cancer.

Journal: ESMO open

Published: November 30, 2020

Showing 1-12 of 68

Last Updated: 09/26/2026